Stock Screener App

Frei -

Installieren

1.91

1.06% 0.02

Tscan Therapeutics Inc (TCRX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	41.69% 3.076	2.171	0.665	1.049	0.536
Operating Expenses	8.61% 41.73	38.42	37.38	33.67	34.65
Interest Income/Expense	1.47% 0.689	0.679	0.784	0.958	0.952
Benefits Costs and Expenses	100.00% -	36.30	36.47	-	-
Costs And Expenses	14.96% 41.73	36.30	36.47	33.67	34.65
Operating Income/Loss	6.63% -38.65	-36.25	-36.71	-32.62	-34.11
Income/Loss From Continuing Operations Before Tax	109.01% 3.076	-34.13	-35.81	1.049	0.536
Income/Loss From Continuing Operations After Tax	8.28% -36.95	-34.13	-35.81	-29.89	-31.66
Net Income/Loss	8.28% -36.95	-34.13	-35.81	-29.89	-31.66
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.04% 129.73	129.68	2.9545	118.70	113.43
Diluted Average Shares	0.04% 129.73	129.68	2.9545	118.70	113.43
Basic Earnings Per Share	7.69% -0.28	-0.26	-0.30	-0.25	-0.28
Diluted Earnings Per Share	7.69% -0.28	-0.26	-0.30	-0.25	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters